MACROGENICS (MGNX) director Meenu Chhabra gets RSUs, options and RSU vesting

Rhea-AI Filing Summary

MACROGENICS INC director Meenu Chhabra reported routine equity compensation activity. On May 19, 2026, she received grants of 3,750 restricted stock units and 22,000 stock options with a conversion or exercise price of $4.5200 per share, both held directly. The options vest in monthly 1/12th increments beginning one month from the grant date, while the RSUs vest one year from grant or the day before the next annual meeting, if earlier.

On May 18, 2026, 3,750 RSUs vested and were exercised into 3,750 shares of common stock, increasing her directly held common stock to 14,750 shares. These transactions reflect compensation-related grants and an RSU vesting and conversion, with no open-market buys or sells reported.

Insider Trade Summary

3,750 shares exercised/converted

Mixed 4 txns

Insider Chhabra Meenu

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to buy)	22,000	$0.00	--
Grant/Award	Restricted Stock Unit	3,750	$0.00	--
Exercise	Restricted Stock Unit	3,750	$0.00	--
Exercise	Common Stock	3,750	$0.00	--

Holdings After Transaction: Stock Option (right to buy) — 22,000 shares (Direct, null); Restricted Stock Unit — 3,750 shares (Direct, null); Common Stock — 14,750 shares (Direct, null)

Footnotes (1)

1. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant. The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier The RSUs vested on May 18, 2026, which was one day prior to the Issuer's 2026 Annual Meeting of Stockholders held on May 19, 2026.

Key Figures

RSU grant: 3,750 RSUs Option grant: 22,000 options Option exercise price: $4.5200 per share +3 more

6 metrics

RSU grant 3,750 RSUs Granted on May 19, 2026 to Meenu Chhabra

Option grant 22,000 options Granted on May 19, 2026 to buy common stock

Option exercise price $4.5200 per share Conversion or exercise price for 22,000 options

RSUs vested and exercised 3,750 RSUs Vested and converted to common stock on May 18, 2026

Common shares held after 14,750 shares Directly held by Meenu Chhabra following RSU exercise

Option vesting schedule 1/12 monthly Options vest in monthly cumulative 1/12th increments

Key Terms

Restricted Stock Unit, Stock Option (right to buy, Exercise or conversion of derivative security, Annual Meeting of Stockholders

4 terms

Restricted Stock Unit financial

"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Stock Option (right to buy financial

"Stock Option (right to buy) with a conversion or exercise price of 4.5200."

Exercise or conversion of derivative security financial

"Transaction code M is described as Exercise or conversion of derivative security."

Annual Meeting of Stockholders financial

"The RSUs vested on May 18, 2026, one day prior to the Issuer's 2026 Annual Meeting of Stockholders."

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chhabra Meenu

(Last) (First) (Middle)

9704 MEDICAL CENTER DRIVE

(Street)

ROCKVILLE MARYLAND 20850

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MACROGENICS INC [ MGNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/18/2026		M		3,750	A	(1)	14,750	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$4.52	05/19/2026		A		22,000		(2)	05/19/2036	Common Stock	22,000	$0	22,000	D
Restricted Stock Unit	$0(1)	05/19/2026		A		3,750		(3)	(3)	Common Stock	3,750	$0	3,750	D
Restricted Stock Unit	$0(1)	05/18/2026		M			3,750	(4)	(4)	Common Stock	3,750	$0	0	D

Explanation of Responses:

1. Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock.

2. The option will vest and become exercisable in monthly, cumulative 1/12th increments (rounded upwards for whole shares) beginning one month from the date of grant.

3. The RSUs will vest one year after the date of grant, or the day prior to the next annual meeting, if earlier

4. The RSUs vested on May 18, 2026, which was one day prior to the Issuer's 2026 Annual Meeting of Stockholders held on May 19, 2026.

Remarks:

	Beth A. Smith, Attorney-in-fact	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What equity awards did Meenu Chhabra receive from MACROGENICS INC (MGNX)?

Meenu Chhabra received 3,750 RSUs and 22,000 stock options. The options have a conversion or exercise price of $4.5200 per share. Both awards were granted on May 19, 2026 as part of her director compensation.

How do the new MACROGENICS INC (MGNX) stock options for Meenu Chhabra vest?

The 22,000 stock options vest monthly over one year. They become exercisable in cumulative 1/12th increments each month, starting one month after the May 19, 2026 grant date, with rounding upward to whole shares.

When will the newly granted RSUs to Meenu Chhabra at MACROGENICS (MGNX) vest?

The 3,750 RSUs vest after roughly one year. They vest one year after the May 19, 2026 grant date, or on the day before the next annual meeting of stockholders, if that occurs earlier.

What happened to Meenu Chhabra’s previously granted RSUs at MACROGENICS (MGNX)?

Previously granted RSUs vested and converted to common stock. On May 18, 2026, 3,750 RSUs vested and were exercised into 3,750 common shares, reducing RSU holdings from that grant to zero.

How many MACROGENICS (MGNX) common shares does Meenu Chhabra hold after these transactions?

She directly holds 14,750 shares of common stock. This figure reflects the 3,750 shares acquired from the RSU vesting on May 18, 2026, as reported in the filing.

Does the MACROGENICS (MGNX) Form 4 show any open-market stock sales or purchases by Meenu Chhabra?

No open-market buys or sells are reported. All transactions are grants of RSUs and options or the exercise of RSUs into common stock, which are compensation-related rather than market trades.